SynthesisOncology reviews2026
Risk factors for return to work in workers who experienced cancer: a systematic review with meta-analysis.
Synthesis in Oncology reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The number of people who have experienced cancer is increasing, and by 2040 cases are expected to rise by 40%, with a high prevalence among working-age individuals. Many people who experienced cancer (pwEC) face reduced work ability due to health, personal, and occupational factors. Therefore, this study aims to identify the main factors that hinder RTW among pwEC. Methods: A systematic literature search was conducted via PubMed, CINAHL, and the Cochrane Library, covering studies published between January 2012 and June 2024. Inclusion criteria focused on studies analysing RTW and Time to RTW in relation to sociodemographic, clinical, and occupational factors. Meta-analysis grouped studies by design, exposure, and effect measures. Fixed or random effects models were applied based on heterogeneity. Risk of bias was assessed using NOS and RoB2 tools. Certainty of evidence was assessed using GRADE tool and STROBE checklist. Results: Among 2,151 screened articles, 43 met the inclusion criteria. Chemotherapy (OR = 0.56, 95% CI: 0.52-0.60) and radiotherapy were associated with a reduced likelihood of RTW. Women were more likely than men to RTW. Manual labour was linked to a lower likelihood of re-employment than white-collar jobs (OR = 0.84, 95% CI: 0.78-0.89). In terms of timing, male sex and chemotherapy delayed the process, whereas radiotherapy accelerated it (HR = 1.03, 95% CI: 1.00-1.06). Conclusion: Identifying barriers to RTW after cancer is essential for improving quality of life and social reintegration in people who have experienced cancer. These findings highlight the complexity of RTW and the need for a personalized approach. However, the evidence is limited by heterogeneity and differences in study design. Trial registration: The protocol was registered in PROSPERO (registration number: CRD42022384364).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.